{"database": "openregs", "table": "documents", "rows": [["FDA-2016-D-1307-0036", "FDA", "FDA-2016-D-1307", "Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities\u2014Questions and Answers; Revised Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2026-06-03T04:00:00Z", 2026, 6, "2026-06-03T04:00:00Z", null, "2026-06-03T18:20:20Z", "2026-11060", 0, 0, "09000064b930af49"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-D-1307-0036"], "units": {}, "query_ms": 0.22741802968084812, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}